Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric citrate in ESRD with hyperphosphatemia
NCT01074125Phase 3Completed
- Sponsor
- Keryx Biopharmaceuticals, Inc.
- Start
- May 2010
- Primary completion
- Nov 2010
- Countries
- 2
01
Overview
A Phase 3 trial of ferric citrate in hyperphosphatemia, sponsored by Keryx Biopharmaceuticals, Inc.. Started May 2010; status: completed.
02
Drugs
ferric citrate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT01074125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01074125.